148 related articles for article (PubMed ID: 38158905)
1. [Long-term probiotic administration for irritable bowel syndrome: a legal need].
Solovyeva OI; Nekrasova AS; Topalova IG; Ponomarenko VA; Tsurtsumiia DB; Ilyashevich IG
Ter Arkh; 2023 Oct; 95(8):679-685. PubMed ID: 38158905
[TBL] [Abstract][Full Text] [Related]
2. Effect of
Sabaté JM; Iglicki F
World J Gastroenterol; 2022 Feb; 28(7):732-744. PubMed ID: 35317278
[TBL] [Abstract][Full Text] [Related]
3. [The effectiveness of a probiotic containing Bifidobacterium longum BB-46 and Enterococcus faecium ENCfa-68 in the treatment of post-infectious irritable bowel syndrome. Prospective randomized comparative study].
Yakovenko EP; Strokova TV; Ivanov AN; Iakovenko AV; Gioeva IZ; Aldiyarova MA
Ter Arkh; 2022 Feb; 94(2):180-187. PubMed ID: 36286741
[TBL] [Abstract][Full Text] [Related]
4. An 8-Week Course of Bifidobacterium longum 35624
Lenoir M; Wienke J; Fardao-Beyler F; Roese N
Probiotics Antimicrob Proteins; 2023 Sep; ():. PubMed ID: 37702965
[TBL] [Abstract][Full Text] [Related]
5. [Clinical efficacy of a modern probiotic for the correction of intestinal microflora in patients with irritable bowel syndrome with diarrhea and antibiotic-associated diarrhea].
Drozdov VN; Shikh EV; Astapovskii AA; Khalaidzheva KN; Solovieva SA; Dorogun OB
Vopr Pitan; 2023; 92(4):92-103. PubMed ID: 37801459
[TBL] [Abstract][Full Text] [Related]
6. The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled Study.
Skrzydło-Radomańska B; Prozorow-Król B; Cichoż-Lach H; Majsiak E; Bierła JB; Kanarek E; Sowińska A; Cukrowska B
Nutrients; 2021 Feb; 13(3):. PubMed ID: 33652763
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of Bifidobacterium infantis 35624 in patients with irritable bowel syndrome: a meta-analysis.
Yuan F; Ni H; Asche CV; Kim M; Walayat S; Ren J
Curr Med Res Opin; 2017 Jul; 33(7):1191-1197. PubMed ID: 28166427
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome.
Whorwell PJ; Altringer L; Morel J; Bond Y; Charbonneau D; O'Mahony L; Kiely B; Shanahan F; Quigley EM
Am J Gastroenterol; 2006 Jul; 101(7):1581-90. PubMed ID: 16863564
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of
Lewis ED; Antony JM; Crowley DC; Piano A; Bhardwaj R; Tompkins TA; Evans M
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32326347
[TBL] [Abstract][Full Text] [Related]
10. A Diet Low in FODMAPs Reduces Symptoms in Patients With Irritable Bowel Syndrome and A Probiotic Restores Bifidobacterium Species: A Randomized Controlled Trial.
Staudacher HM; Lomer MCE; Farquharson FM; Louis P; Fava F; Franciosi E; Scholz M; Tuohy KM; Lindsay JO; Irving PM; Whelan K
Gastroenterology; 2017 Oct; 153(4):936-947. PubMed ID: 28625832
[TBL] [Abstract][Full Text] [Related]
11. The Effectiveness of Synbiotic Preparation Containing
Skrzydło-Radomańska B; Prozorow-Król B; Cichoż-Lach H; Majsiak E; Bierła JB; Kosikowski W; Szczerbiński M; Gantzel J; Cukrowska B
Nutrients; 2020 Jul; 12(7):. PubMed ID: 32635661
[TBL] [Abstract][Full Text] [Related]
12. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
[TBL] [Abstract][Full Text] [Related]
13. Effect of a symbiotic preparation on the clinical manifestations of irritable bowel syndrome, constipation-variant. Results of an open, uncontrolled multicenter study.
Colecchia A; Vestito A; La Rocca A; Pasqui F; Nikiforaki A; Festi D;
Minerva Gastroenterol Dietol; 2006 Dec; 52(4):349-58. PubMed ID: 17108864
[TBL] [Abstract][Full Text] [Related]
14. A randomized placebo-controlled clinical trial of a multi-strain probiotic formulation (Bio-Kult®) in the management of diarrhea-predominant irritable bowel syndrome.
Ishaque SM; Khosruzzaman SM; Ahmed DS; Sah MP
BMC Gastroenterol; 2018 May; 18(1):71. PubMed ID: 29801486
[TBL] [Abstract][Full Text] [Related]
15. A Mixture of 3 Bifidobacteria Decreases Abdominal Pain and Improves the Quality of Life in Children With Irritable Bowel Syndrome: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Crossover Trial.
Giannetti E; Maglione M; Alessandrella A; Strisciuglio C; De Giovanni D; Campanozzi A; Miele E; Staiano A
J Clin Gastroenterol; 2017 Jan; 51(1):e5-e10. PubMed ID: 27306945
[TBL] [Abstract][Full Text] [Related]
16. I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life.
Lorenzo-Zúñiga V; Llop E; Suárez C; Alvarez B; Abreu L; Espadaler J; Serra J
World J Gastroenterol; 2014 Jul; 20(26):8709-16. PubMed ID: 25024629
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of probiotics in the treatment of irritable bowel syndrome: A systematic review and meta-analysis of randomised clinical trials using ROME IV criteria.
Konstantis G; Efstathiou S; Pourzitaki C; Kitsikidou E; Germanidis G; Chourdakis M
Clin Nutr; 2023 May; 42(5):800-809. PubMed ID: 37031468
[TBL] [Abstract][Full Text] [Related]
18. Role of gut microflora and probiotic effects in the irritable bowel syndrome.
Fanigliulo L; Comparato G; Aragona G; Cavallaro L; Iori V; Maino M; Cavestro GM; Soliani P; Sianesi M; Franzè A; Di Mario F
Acta Biomed; 2006 Aug; 77(2):85-9. PubMed ID: 17172187
[TBL] [Abstract][Full Text] [Related]
19. Probiotic Bifidobacterium longum NCC3001 Reduces Depression Scores and Alters Brain Activity: A Pilot Study in Patients With Irritable Bowel Syndrome.
Pinto-Sanchez MI; Hall GB; Ghajar K; Nardelli A; Bolino C; Lau JT; Martin FP; Cominetti O; Welsh C; Rieder A; Traynor J; Gregory C; De Palma G; Pigrau M; Ford AC; Macri J; Berger B; Bergonzelli G; Surette MG; Collins SM; Moayyedi P; Bercik P
Gastroenterology; 2017 Aug; 153(2):448-459.e8. PubMed ID: 28483500
[TBL] [Abstract][Full Text] [Related]
20. The efficacy of Bifidobacterium quadruple viable tablet in the treatment of diarrhea predominant irritable bowel syndrome: protocol for a randomized, double-blind, placebo-controlled, multicenter trial.
Bai T; Zeng H; Long Y; Li X; Sun X; Lan Y; Gao L; Zhang L; Feng Z; Hou X
Trials; 2020 Jun; 21(1):597. PubMed ID: 32605578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]